<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00703898</url>
  </required_header>
  <id_info>
    <org_study_id>0327/3619</org_study_id>
    <nct_id>NCT00703898</nct_id>
  </id_info>
  <brief_title>Durability of Nevirapine-Based Antiretroviral Regimen</brief_title>
  <official_title>Durability of Stavudine, Lamivudine and Nevirapine Among Advanced HIV-1 Infected Patients With/Without Prior Co-Administration of Rifampicin: A 144-Week Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bamrasnaradura Infectious Diseases Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bamrasnaradura Infectious Diseases Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although nevirapine is used as an alternative to efavirenz for initial regimen in developed
      countries, nevirapine has still been a key antiretroviral drug in many resource-limited
      countries including Thailand due to its accessibility and affordability. In addition, a
      component of stavudine and lamivudine is still widely used as a backbone in the
      antiretroviral regimen in this setting.To date, data on the durability of a regimen of
      stavudine, lamivudine and nevirapine are very limited, particularly from the resource-limited
      settings.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date>April 2010</completion_date>
  <primary_completion_date>December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients with undetectable plasma HIV-1 viral load</measure>
    <time_frame>240 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Actual">140</enrollment>
  <condition>HIV Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nevirapine</intervention_name>
    <description>200 mg/day twice a day</description>
    <other_name>GPO-vir</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-infected individuals ≥15 years of age

          -  CD4 cell count &lt;350 cells/mm3

          -  Willing to participate and give consent form

        Exclusion Criteria:

          -  previous antiretroviral therapy

          -  pregnancy

          -  receiving a medication that has drug-drug interactions with NVP or RFP

          -  aspartate aminotransferase (AST) and alanine aminotransferase (ALT) &gt;5 times of upper
             limit of normal range
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weerawat Manosuthi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bamrasnaradura Infectious Diseases Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medicine, Bamrasnaradura Infectious Diseases Institute</name>
      <address>
        <city>Nonthaburi</city>
        <zip>11000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2008</study_first_submitted>
  <study_first_submitted_qc>June 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2008</study_first_posted>
  <last_update_submitted>July 7, 2008</last_update_submitted>
  <last_update_submitted_qc>July 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Weerawat Manosuthi</name_title>
    <organization>Bamrasnaradura Infectious Diseases Institute</organization>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>nevirapine</keyword>
  <keyword>durability</keyword>
  <keyword>AIDS</keyword>
  <keyword>Treatment Naïve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nevirapine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

